Immunomarking for the Profile of Tumor Proliferation (Ki67) and Cell Death (TUNEL) in Relation to the Presence of Recurrence in Biopsy Samples from Patients with Breast Cancer. This evidence concerns the gene MKI67 and breast carcinoma.